IDEAS home Printed from https://ideas.repec.org/
MyIDEAS: Log in (now much improved!) to follow this author

Jörg C. Mahlich

This is information that was supplied by Jörg Mahlich in registering through RePEc. If you are Jörg C. Mahlich, you may change this information at the RePEc Author Service. Or if you are not registered and would like to be listed as well, register at the RePEc Author Service. When you register or update your RePEc registration, you may identify the papers and articles you have authored.

Personal Details

First Name:Jörg
Middle Name:C.
Last Name:Mahlich
Suffix:
RePEc Short-ID:pma997
http://www.xing.com/profile/Joerg_Mahlich
Wien, Austria
http://econ.univie.ac.at/

: [+43] 1-4277-37401
[+43] 1-4277-9374
Oskar-Morgenstern-Platz 1, A-1090 Vienna
RePEc:edi:wiwuwat (more details at EDIRC)
in new window
  1. Mahlich, Jörg & Sindern, Jörn & Suppliet, Moritz, 2014. "Vergleichbarkeit internationaler Arzneimittelpreise: Internationale Preisreferenzierung in Deutschland durch das AMNOG," DICE Ordnungspolitische Perspektiven 60, University of Düsseldorf, Düsseldorf Institute for Competition Economics (DICE).
  2. Mahlich, Jörg C. & Roediger-Schluga, Thomas, 2006. "The Determinants of Pharmaceutical R&D Expenditures: Evidence from Japan," MERIT Working Papers 015, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
  3. Mahlich ,Jörg C. & Roediger-Schluga,Thomas, 2001. "The Changing Nature of Pharmaceutical R&D - Opportunities for Asia?," Research Memorandum 001, Maastricht University, Maastricht Economic Research Institute on Innovation and Technology (MERIT).
  1. Mona Groß & Annika Herr & Martin Hower & Alexander Kuhlmann & Jörg Mahlich & Matthias Stoll, 2016. "Unemployment, health, and education of HIV-infected males in Germany," International Journal of Public Health, Springer;Swiss School of Public Health (SSPH+), vol. 61(5), pages 593-602, June.
  2. Philipp Hafner & Jörg C. Mahlich, 2016. "Determinants of physician's office visits and potential effects of co-payments: evidence from Austria," International Journal of Health Planning and Management, Wiley Blackwell, vol. 31(3), pages 192-203, 07.
  3. Mahlich Jörg & Sindern Jörn & Suppliet Moritz, 2015. "Vergleichbarkeit internationaler Arzneimittelpreise," Perspektiven der Wirtschaftspolitik, De Gruyter, vol. 16(2), pages 164-172, June.
  4. Stephan Eger & Jörg Mahlich, 2014. "Pharmaceutical regulation in Europe and its impact on corporate R&D," Health Economics Review, Springer, vol. 4(1), pages 1-9, December.
  5. Jan Zeidler & Jörg Mahlich & Wolfgang Greiner & Stephan Heres, 2013. "Cost Effectiveness of Paliperidone Palmitate for the Treatment of Schizophrenia in Germany," Applied Health Economics and Health Policy, Springer, vol. 11(5), pages 509-521, October.
  6. Jan Zeidler & Jörg Mahlich & Wolfgang Greiner & Stephan Heres, 2013. "Erratum to: Cost Effectiveness of Paliperidone Palmitate for the Treatment of Schizophrenia in Germany," Applied Health Economics and Health Policy, Springer, vol. 11(6), pages 689-689, December.
  7. Axel Mühlbacher & Matthias Stoll & Jörg Mahlich & Matthias Nübling, 2013. "Evaluating the concordance of physician judgments and patient preferences on AIDS/HIV therapy - a Discrete Choice Experiment," Health Economics Review, Springer, vol. 3(1), pages 1-11, December.
  8. Hans Dimai & Kurt Redlich & Monika Peretz & Fredrik Borgström & Uwe Siebert & Jörg Mahlich, 2012. "Economic burden of osteoporotic fractures in Austria," Health Economics Review, Springer, vol. 2(1), pages 1-10, December.
  9. Jörg Mahlich, 2011. "R&D Management Of Japanese Pharmaceutical Firms," International Journal of Innovation and Technology Management (IJITM), World Scientific Publishing Co. Pte. Ltd., vol. 8(02), pages 211-226.
  10. Jörg Mahlich, 2010. "Patents and performance in the Japanese pharmaceutical industry: An institution-based view," Asia Pacific Journal of Management, Springer, vol. 27(1), pages 99-113, March.
  11. Jörg Mahlich & Thomas Roediger-Schluga, 2006. "The Determinants of Pharmaceutical R&D Expenditures: Evidence from Japan," Review of Industrial Organization, Springer;The Industrial Organization Society, vol. 28(2), pages 145-164, 03.
  12. Mahlich Jörg, 2005. "Wirtschaftspolitik für wissensintensive Branchen am Beispiel der Pharmaindustrie," Zeitschrift für Wirtschaftspolitik, De Gruyter, vol. 54(3), pages 366-390, December.
    RePEc:wsi:ijitmx:v:08:y:2011:i:02:p:211-226 is not listed on IDEAS
NEP is an announcement service for new working papers, with a weekly report in each of many fields. This author has had 1 paper announced in NEP. These are the fields, ordered by number of announcements, along with their dates. If the author is listed in the directory of specialists for this field, a link is also provided.
  1. NEP-GER: German Papers (1) 2014-05-24
  2. NEP-HEA: Health Economics (1) 2006-05-27
  3. NEP-INO: Innovation (1) 2006-05-27
  4. NEP-SEA: South East Asia (1) 2006-05-27
  5. NEP-TID: Technology & Industrial Dynamics (1) 2006-05-27

Most cited item

Most downloaded item (past 12 months)

Access and download statistics for all items

Co-authorship network on CollEc

For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, Jörg Mahlich should log into the RePEc Author Service

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.

This information is provided to you by IDEAS at the Research Division of the Federal Reserve Bank of St. Louis using RePEc data.